Alexander Chen is starting his PhD in Chemical Engineering at the University of Cambridge, UK. He will be closely involved in the investigation of membrane associating polymers, therapeutic nanoparticles and cell preservation experiments by applying experimental techniques in chemistry, cell biology and pharmacology. Alex holds a B.S. in chemistry from the University of Minnesota-Twin Cities, USA and an MSc in Pharmacology from the University of Oxford, UK. He conducted his Master thesis at the Swiss Federal Institute of Technology Zurich (ETH Zurich) at the lab for professor Martin Fussenegger on establishing a second messenger reporter system for studying an important immune pathway with bioengineering techniques. Additionally, Alex worked at the Johns Hopkins Medical Institutions on cancer research and co-authored in several publications on immune- and gene therapy. In one of the projects he participated in, the combination of chemo- and immunotherapy cure 90% of the cancer in murine models. Aside from his diverse academia experience, Alex worked in the biotechnology industry in the USA before joining the SNAL network.